Literature DB >> 29933843

IgA nephropathy: new insights into the role of complement.

Jürgen Floege1, Mohamed R Daha2.   

Abstract

Glomerular complement deposition is common in IgA nephropathy, and recent genome-wide association studies point to a role of complement factor H and complement factor H-related proteins in disease susceptibility. A number of recent studies have now documented elevated levels of some factor H-related proteins in IgA nephropathy, which might contribute to enhanced complement activation.
Copyright © 2018 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29933843     DOI： 10.1016/j.kint.2018.03.009

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  [Immunoglobulin A nephropathy].

Authors:  C Seikrit; T Rauen; J Floege
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

2.  Safety, Tolerability and Efficacy of Narsoplimab, a Novel MASP-2 Inhibitor for the Treatment of IgA Nephropathy.

Authors:  Richard A Lafayette; Brad H Rovin; Heather N Reich; James A Tumlin; Jürgen Floege; Jonathan Barratt
Journal:  Kidney Int Rep       Date:  2020-08-13

Review 3.  [The complement system-a "hot topic" not only for kidney diseases].

Authors:  Kerstin Amann; Christoph Daniel; Maike Büttner-Herold
Journal:  Pathologe       Date:  2020-05       Impact factor: 1.011

4.  Anaphylatoxins enhance Th9 cell recruitment via the CCL20-CCR6 axis in IgA nephropathy.

Authors:  Xinyue Hu; Juntao Feng; Shuanglinzi Deng; Jiale Tang; Zhonghua Liao; Lisha Luo; Liying Luo; Ting Meng; Guanghui Gong; Xiaozhao Li
Journal:  J Nephrol       Date:  2020-02-08       Impact factor: 3.902

5.  Identification of susceptibility locus shared by IgA nephropathy and inflammatory bowel disease in a Chinese Han population.

Authors:  Dianchun Shi; Zhong Zhong; Meng Wang; Lu Cai; Dongying Fu; Yuan Peng; Lin Guo; Haiping Mao; Xueqing Yu; Ming Li
Journal:  J Hum Genet       Date:  2019-12-19       Impact factor: 3.172

Review 6.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Authors:  Dana V Rizk; Nicolas Maillard; Bruce A Julian; Barbora Knoppova; Todd J Green; Jan Novak; Robert J Wyatt
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 7.  Complement Inhibitors in Clinical Trials for Glomerular Diseases.

Authors:  Peter F Zipfel; Thorsten Wiech; Ramona Rudnick; Sara Afonso; Fermin Person; Christine Skerka
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 8.  Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.

Authors:  Marion Ort; Jasper Dingemanse; John van den Anker; Priska Kaufmann
Journal:  Front Immunol       Date:  2020-12-10       Impact factor: 7.561

9.  Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.

Authors:  Peter Garred; Andrea J Tenner; Tom E Mollnes
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Epidemiology and Pathophysiology of Glomerular C4d Staining in Native Kidney Biopsies.

Authors:  Cinthia B Drachenberg; John C Papadimitriou; Preeti Chandra; Abdolreza Haririan; Susan Mendley; Matthew R Weir; Mario F Rubin
Journal:  Kidney Int Rep       Date:  2019-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.